chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Congestion and headache started within an hour. Over the next 6 hours severe exhaustion, body aches (muscular pain), shortness of breath upon exertion, chest pressure and heaviness, migraines, fever, chills, cough and runny nose all started and progressed for 2 days. I didn't leave the bed for 3 days. Symptoms lasted 7 full days, and I'm still having trouble being short of breath. Severe injection site reaction causing a 3" diameter reaction site-fever, itching, pain, and a 1.5" diameter knot that lasted 3 weeks.
Pt recvd immun & 2 hrs later devel sx of fever, irritability, vomiting, lethargy & t102; pt being treated w/Ceclor for persisting BOM @ time of vax;
Seen cough 10/10/12 dx asthma, PNA Rx Albuterol/Z-PAK. Vaccines - FLUZONE, HPV, MENACTRA given. 10/11 Redness 4x5 in (L) deltoid. Seen 10/12 possible cellulitis. Rx KEFLEX, but Mom did warm compress and resolved in few hours. No fevers.
Case number PHEH2014US021537, is an initial spontaneous report from a pharmacist received on 23 OCT 2014. This report refers to a 63-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The pharmacist reported that the safety needle was not tightly screwed to the syringe prior to the vaccination with FLUVIRIN. When the FLUVIRIN 2014/2015 (batch number: 145404) was administered on 23 OCT 2014 all the vaccine fell down the side of the patient arm. The pharmacist reported that the leaking was caused by the technique (drug administration error) only and not due to FLUVIRIN. No adverse event was reported.
Pt came in today on 05/07/2022 around noon and asked me to look at a "rash" near the vaccine site. He received his vaccine nearly 3 weeks ago, but this "rash" didnt appear till 05/05/2022. Upon inspection it looked more like two small blisters around the right anterior deltoid, total lesion was about the size of a penny. Was not raised and was cool to the touch. I recommended following up with pcp to make sure he didnt need an antibiotic or additional care. Denied fever, chills, or shortness of breath. Only noticed due to area itching. Did also state he worked in the yard on Thursday but didnt recall any kind of injury. Reporting this even due to how close the area is to the vaccination site and it being within 30 days of administration
Above are the two vaccinations I received. The first 1/20/2021. The second  2/8/2021.  I am a healthcare provider. I have NO existing history of thyroid dysfunction prior to the vaccination?no signs or symptoms. After the vaccination, continued to be asymptotic outwardly for any thyroid dysfunction. My husband and I were beginning to start a family. I noticed my menstrual cycle getting extremely light (only lasting for a few days). This seemed  abnormal but I didn?t think anything of it until we were unable to convenience, despite exhausting all options. At the OB/GYN a thyroid panel was drawn resulting in TSH levels of <0.0005. Another panel was drawn a month later, with the same results. I was unable to receive a primary care visit until 1/2022 when my labs were run again with the same results. Imaging and function tests confirmed: Grave?s Disease.
A serious spontaneous report of fever and non-serious report of H1N1 LAIV was administered to 13 weeks pregnant female was received from a non-health professional concerning a 20-year-old female, subsequent to H1N1, Intranasal. The patient's past medical history is unknown. The patient had no concomitant medications. The patient's obstetrical history included gravida one, para one. The date of last menstrual period was 02-Sep-2009, estimated date of delivery was approximately 09-Jun-2010. The patient was 11 weeks pregnant at the time of vaccination. On 02-Dec-2009, the patient received H1N1, Intranasal for an unknown indication. The patient has remained healthy, never developed side-effects and never developed flu-like symptoms since vaccination. The patient delivered a baby girl without complications. The only complication was that, 12 hours prior to delivery, the patient experienced a fever. She was admitted to the hospital and treated with antibiotics. Twelve hours after the fever, she delivered vaginally. The birth occurred just a few days under 40 weeks in Jun-2010. Both the mom and baby were healthy after delivery and they were released from the hospital 48 hours after delivery. The outcome of fever was unknown and the outcome of H1N1 LAIV was administered to 13 weeks pregnant female was resolved. Additional information was received on 17-Dec-2009 and incorporated into the narrative: The patient's obstetrical history, LMP, EDD was added. Additional information was received on 12-Jul-2010 and incorporated into the narrative: Pregnancy Outcome was added. Additional information was received on 06-Aug-2010 and incorporated into the narrative: Adverse event, gestation age of child and mode of delivery.
The second dose of vaccine was administered, in error, on the 22nd day (given too soon) following the first dose. The second dose should have been administered on March 17th but was given on March 10th.  In the morning following the vaccination, caregiver noted individual to be very weak, fatigued and complained of body aches, requiring assistance to get out of bed and required more assistance with mobility than what is usually needed for a period of 2 days following the vaccine.
Death, brain lesions, turbo cancer. Diagnosed in June and passed away in October. She was healthy and vibrant prior to her murder.
Information has been received on 30-JUN-2017 from a pharmacist regarding a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 26-JUN-2017, the patient was vaccinated with a dose of ZOSTAVAX lot # M035696, expiration 07-NOV-2017 subcutaneous for prophylaxis which was improperly stored.  Concomitant therapies included sterile diluent (STERILE DILUENT) lot number M026304 expiration 13-MAR-2019. The pharmacist confirmed that no adverse events were present for the patient. The vaccine was stored at temperatures of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 24 hours 30 minutes and at temperatures of 15 degrees Fahrenheit to 46 degrees Fahrenheit for 8 hours 39 minutes. The pharmacist reported a previous temperature excursion but did not have the details. The call was made due to a data logger. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1707USA004031:
hypotensive; hypoglycemia; dizziness; significant local reaction; Initial information received on 30-Jul-2019 regarding an unsolicited valid non-serious case received from a physician.  This case was linked to 2019SA209617 (same reporter).  This case involves a 11 years old female patient who experienced dizziness, hypotensive, hypoglycemia and significant local reaction, while she received vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PARACETAMOL (TYLENOL [PARACETAMOL]); and MENINGOCOCCAL VACCINE B RFHBPA/FHBPB (TRUMENBA).  On 26-Jul-2019, the patient received a 0.5 ml second dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U6522AB in the right deltoid.  On unknown date, The patient developed a non-serious dizziness, hypotensive (hypotension), hypoglycemia (hypoglycaemia) significant local reaction (local reaction) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  No lab test reported.  Final diagnosis was significant local reaction, hypoglycemia, hypotensive and dizziness.   It was not reported if the patient received a corrective treatment.  The patient outcome was not reported..
Injection site is inflamed with localized edema and itching.  Some tightness and slight pain, increases with movement.  Area had redness and feels hot to touch.  Cont. x 5 days.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 11:39 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 11:39 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 45.44 for dose administered on 03-Apr-2021 at 11:39 AM.  No concomitant medications were reported.  Batch number 030B21A underwent temperature excursion on 31-Mar-2021 with temperature 32 degrees Fahrenheit between 8AM-9AM and on 03-Apr-2021 with temperature 34 degrees Fahrenheit at 9AM. 14 vials of same batch number were moved to fridge on 30-Mar-2021, moved to clinic on 31-Mar-2021 and beyond use date for these 14 vials were reported as 29-Apr-2021. Another 20 vials of same batch number were moved to fridge on 30-Mar-2021, moved to clinic on 03-Apr-2021 and beyond use date for these 20 vials were reported as 29-Apr-2021  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Immediately after vaccination, patient became very sleepy and difficult to awaken. This was different from her normal behavior at that age. She was not interested in nursing and slept for 4 hours. When she woke up, she started screaming and was inconsolable. She had a high pitched screaming cry that lasted for 6 hours. She was very tense and would not make eye contact or soothe. We tried the following comfort measures with no decrease in symptoms: nursing, bottle, rocking her in a dark room, warm bath, cool packs to vaccination site. After about 6 hours she fell asleep, she was limp and did not wake up for 8 hours to nurse (not typical for her at this age). She had redness and swelling and tenderness to vaccination site for days. I called the pediatrician office the next day (1/22/2014) and spoke with a nurse who advised me to give TYLENOL and told me "it's not the vaccines, some babies just cry a lot."
Moderna COVID-19 Vaccine EUA -I first got a symptom the day after the vaccine which was 8/21/21, waking up at 4am with chills, then very sore arm on the injection site. The area was red, warm to touch, tender, raised, very sensitive to touch and I could hardly move my arm. i took Ibuprofen for pain, it went away for few hours. I also felt very nauseated but no vomiting. The next day 8/22/21, I woke up with much sore of an arm, less red on the site of injection but still raised, tender and still painful to touch. no chills this time but still having a hard time moving my arm.
Patient received moderna COVID19 vaccine on 2/4/21, 03/04/21, and 11/11/21. Presented to ER on 1/2/22 and was admitted. Positive by nucleic acid amplificationon 1/2/22, negative on 1/4/22 with the cepheid test. Came to ER due to fall earlier that day. Did not receive covid treatment. Discharged on 1/5/22
Chronic headache daily. Starts in the upper right and sometimes in the crown of the head.
pt became pale w/shallow breathing noted by mom & then paramedics; taken to hosp ER where pt was followed & recovered spontaneously;
Information has been received from a physician concerning a 2-month-old male who on 22-JUN-2007 was vaccinated with a 2mL PO dose of Rotateq (Lot # "2028U"). Suspect therapy that day included a dose of HIB conj-hepatitis B vaccine, a dose of PREVNAR, a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, and a dose of "ITV". On 30-JUN-2007 the patient passed away. CPR was noted. The autopsy medical examiner gave verbal to the mother stating that no cause has been determined. At the time of the report, the physician still did not have the autopsy report. No further information was provided. There was no product quality complaint. The event was considered to be an other important medical event by the reporter. Additional information has been requested.
father child said right side face/neck swelling and rash. Father said getting worse (11/7/07)
patient unable to form sentence, slurred speech, headache, nausea without vomiting, feeling flushed.
Intermittent itchiness throughout every day on bilateral upper and lower arms, chest, upper back.  I have been treating symptoms with maintaining hygiene through daily showers and using topical non-scented lotions.  Symptoms are mild enough that I have chosen not to go into a clinic for treatment.
Four hours after DTap, PV7, IPV, and HIB vaccination, the pt had a screaming episode lasting 3 hours.
HIVES TYPE RASH - L ARM THEN R ARM - OVER THE BACK BUTTOCKS AND BACK OF BOTH LEGS.
Soreness of arm; Depression; Swollen glands of breast; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm), DEPRESSION (Depression) and LYMPHADENOPATHY (Swollen glands of breast) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm), DEPRESSION (Depression) and LYMPHADENOPATHY (Swollen glands of breast). At the time of the report, PAIN IN EXTREMITY (Soreness of arm), DEPRESSION (Depression) and LYMPHADENOPATHY (Swollen glands of breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Arm swollen and erythematous from shoulder to elbow. Recommended cold compresses, rest, Tylenol as needed. Recheck if worsens.
PATIENT IS UNDER 18 YEARS OLD AND RECEIVED MODERNA INSTEAD OF PFIZER VACCINE.  PATIENT REPORTED FEVER FOR 2 DAYS, TROUBLE SLEEPING, HEADACHES AND FATIGUE.  PATIENT STATES SHE IS NOW ONLY HAVING TROUBLE SLEEPING SINCE HER VACCINATION.
Never received their fifth dtap; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 8-year-old patient who received DTPa (DTPa vaccine) for prophylaxis.   Previously administered products included DTPa Vaccine (received 4 doses on an unknown date).   On an unknown date, the patient received the 5th dose of DTPa vaccine. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The Nurse reported that the patient had not and never received their fifth DTPa so per CDC guidelines they should get DTPa, which led to incomplete course of vaccination. The reporter did not consent to follow up. The HCP declined to provide additional information and cannot confirm that the missed Dtap was Infanrix.  Boostrix had not been administered to the patient yet.  The HCP declined follow up.
RN called for vaccine stability evaluation after TE on 12/23/22 and reported that 1 dose of  VARIVAX  was administered on 12/27/22. No additional AEs, no PQCs reported.; RN called for vaccine stability evaluation after TE on 12/23/22 and reported that 1 dose of  VARIVAX  was administered on 12/27/22. No additional AEs, no PQCs reported.; This spontaneous report was received from a healthcare professional referring to a 15-month-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 23-DEC-2022, a dose of varicella virus vaccine live (oka/merck) (VARIVAX) underwent a temperature excursion (TE) (temperature and time not reported). On 27-DEC-2022, the patient was vaccinated with the improperly stored dose varicella virus vaccine live (oka/merck) (VARIVAX) (lot #U010399 and expiration date: 01-APR-2023) subcutaneous injection, 0.5 mL/once as prophylaxis (strength and route of administration were not provided) (Product storage error). No additional adverse events (AEs) were reported.
swelling at injection sited; injection sited redness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 18Oct2023 at 10:00 as dose 1, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "afib" (unspecified if ongoing). Concomitant medication(s) included: FLU VACCINE VII taken for influenza immunisation as dose number unknown, single; ELIQUIS; COREG; CALCIUM+D3; PRILOSEC [OMEPRAZOLE]. The following information was reported: VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "swelling at injection sited"; VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "injection sited redness".  Additional information: There was no covid prior vaccination. Did not covid tested post vaccination. No Known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About three hours after the vaccine, I had upper abdominal pain and cramping. I started vomiting five hours after the shot for 2-3 hours. I also had some vomiting the next day for about an hour. I was still queasy for a couple of days afterward but I recovered.
almost felt like shingles; difficulty breathing; lesser sense of taste; itchy; burning; rash; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date was unknown), via an unspecified route of administration, administered in the left arm on 04Feb2021 at 14:30 as a single dose for COVID-19 immunisation.  Medical history included hospitalized for pneumonia in Sep2020 and treated with "mega-doses" of prednisone, antibiotics (unspecified) and oxygen wherein he recovered, came off oxygen for 1.5 months, but then after Christmas 2020, went back on the oxygen, from 07Jan2021 through 12Jan2021 the patient was hospitalized again and CT scans and cultures were performed on his lungs which returned a diagnosis of MAC complex.  The patient is awaiting treatment for this after lung cultures mature. The patient also has chronic obstructive pulmonary disease (COPD) from an unknown date and unknown if ongoing diagnosed 20 years ago, congestive heart failure (CHF), stomach issues, rash also on a portion of his face and eye sensitivity all from an unknown date and unknown if ongoing. The patient also had a heart attack and a triple bypass in May2020 and ongoing diverticulitis that has been going on forever since an unknown date. The patient is taking "a lot of other meds" (unspecified) for heart, lungs and digestive things. The patient previously got a regular flu shot (unspecified) and got feverish, chills, achy and his arm hurts. After the patient received the first dose of the vaccine on 04Feb2021, that day and night he had no symptoms. On 05Feb2021, the patient developed an itchy, burning, rash everywhere but legs and feet that "almost felt like shingles", which escalated over 5 days, tapered off a little on Wednesday, Thursday it was receding, by Friday 12Feb2021 it was basically gone.  The patient went to a dermatologist office and they did not know about the rash. He called his pulmonologist and they told him not to get the second dose due to his underlying conditions. He was in the hospital back in Jan2021 and they found something on his lung and he is now working with infectious disease people, they told him to see an allergist, he cancelled his appointment for the second dose. The patient wants to know if this rash is being reported and was hoping that maybe someone would have seen or heard of something like this. The patient also reported that he has a lessened sense of taste that started on an unspecified date, around Tuesday, and he has had some difficulty breathing during all of this as well, unsure if it is related to the vaccine or his underlying condition. The outcome of difficulty breathing and lesser sense of taste was not recovered. The outcome of the event almost felt like shingles was unknown while the outcome of the other events was recovering.  Information on the lot/batch number has been requested.
Swelling and redness that was 10 inches down my arm and around deltoid. Hives, chills, diarrhea, itchy, hard lump at site of vaccine, right side of face swelled. Vaccine given in right arm. Also blistering and peeling of skin. Treatment included Benadryl and Prednisone.
On both my 2nd dose in March 2021 and now my booster (this vaccine) in Dec, I have suffered a persistent dry cough, chest tightness and some shortness of breath which continues 3 weeks so far after the booster shot. On my 2nd dose, the cough lasted 16 weeks. In both cases, these symptoms were exactly the same and started immediately after the vaccine. I am by all measures, a very healthy, fit individual and the symptoms have inhibited my ability to exercise fully.
Pt. REPORTED INNER UPPER LEFT ARM PAIN WHEN SHE WAS AT THE PHARMACY. SHE REPORTED SORENESS TO TOUCH AND PINPOINTED THE PAIN CLOSE TO HER BICEP, BUT NOT NEAR HER DELTOID.
Information has been received from a physician concerning a 17 year old male who on 8/6/99 was vaccinated IM with the second dose of Hep B. On 8/8/99, the pt experienced an itchy, smooth, erythematous rash on his hands, trunk and legs that lasted a total of 6-7 days. It was noted that the pt began using a new soap and was also exposed to grass. The pt was treated with Benadryl and then was switched to treatment with hydroxine. The rash has since resolved, however the itching persists. Additional information has been requested.